Eton Pharmaceutcials, Inc. Common Stock (ETON)
Eton Pharmaceuticals, Inc. (ETON) is a specialty pharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. It aims to provide innovative solutions for underserved patient populations through the development of injectable, oral, and topical formulations. The company leverages its expertise in formulation development and regulatory affairs to bring new treatments to market.
Company News
•  Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13th straight quarter of sequential product sales growth•  Acquired PKU GOLIKE®, launched Nitisinone, and submitted a new drug application (NDA) for product candidate ET-400•  Management to hold conference call today at 4:30pm ET
Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of -125% and 5.03%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. Rigetti Computing, Inc. (NASDAQ: RGTI) shares climbed 51.2% to $2.48 following a narrower-than-expected quarterly loss. Telesat Corporation (NASDAQ: TSAT) gained 47.2% t...
U.S. stocks end higher on Wednesday with Nasdaq Composite logging its longest win streak since September.
4 Biotech Penny Stocks To Watch, January 2023 The post Best Penny Stocks To Buy? 4 To Watch In January 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.